Truqap is a kinase inhibitor that works by blocking pathways that help the most cancers cells endure and mature, so reduces cancer progress. Truqap is from a class of medicines named an AKT inhibitor. Truqap gained FDA approval on November seventeen, 2023, after good final results within the CAPItello-291 Section https://franko776alv9.bloggosite.com/profile